Pharmaceutical labs face constant pressure to deliver precise, reproducible dissolution results while staying compliant with regulatory standards. ERWEKA’s Digital Dissolution Offline System ...
Stockholders expected to receive $0.028 and $0.045/shr Co. writes down value of clinical-stage drug Riquent Oct 15 (Reuters) - La Jolla Pharmaceutical Co has called a special meeting of stockholders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results